Company intelligence / Profile preview
Ore Pharmaceuticals
Gaithersburg, Maryland, United Statesbiospace.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Ore Pharmaceuticals focused on identifying new indications for existing clinical-stage compounds using a proprietary integrative pharmacology platform. Lead programs included GL1001 for gastrointestinal disorders, romazarit for metabolic diseases, tiapamil hydrochloride for CNS disorders, and SCH‑58500 targeting p53 in oncology. Some programs reached Phase II or were pending further development/outlicensing. The company ceased active operations after 2011.
- Therapeutic areas
- GastroenterologyOncologyNeurology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Roche (in-license/development rights to romazarit and other compounds)Steel Partners Ltd. (major investor with board representation post-investment)
Beyond the preview
Go deeper on Ore Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ore Pharmaceuticals.